Luregn Schlapbach is Professor and Head of the 41-bed multidisciplinary Paediatric and Neonatal Intensive Care Unit at the University Children`s Hospital Zurich, Switzerland. After having worked during a decade as paediatric intensivist in Australia including being a Staff Specialist in the PICU at Queensland Children`s Hospital in Brisbane, Australia, he maintains an active research program on Sepsis, Infection, and Inflammation in Critically Ill Children at the Child Health Research Centre, University of Queensland. Luregn is Past Chair of the ANZICS Paediatric Study Group.
Luregn was group head on the Pediatric Surviving Sepsis Campaign, and is Co-Chair of the international Paediatric Sepsis Definition Taskforce, and is in the Global Sepsis Alliance Executive. He has been leading observational, genomic, and interventional pediatric sepsis studies and is involved in international consortia on life-threatening childhood infections. Luregn is in the steering board of several NHMRC funded paediatric interventional trials.
Luregn`s research has focused on sepsis and life-threatening infections in critically ill neonates and children, including aspects such as epidemiology, sepsis markers, outcomes and genomics in this highly vulnerable patient group. He is interested in improving our understanding of why some children become critically unwell because of infections, and in developing better approaches to allow early recognition and targeted treatment of sepsis and severe infections in children.